HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MME

Also Known As:
1,2,3,4,9,9-hexachloro-1,4,4a,5,8,8a-hexahydro-6- methyl-6,7-epoxy-1,4-methanonaphthalene; 3,6-Methanonaphth(2,3-b)oxirene, 3,4,5,6,8,8-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-1a-methyl-, (1aalpha,2abeta,3alpha,6alpha,6abeta,7aalpha)-
Networked: 523 relevant articles (21 outcomes, 56 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Mutti, Luciano: 11 articles (01/2021 - 11/2002)
2. Ranzato, Elia: 6 articles (10/2018 - 01/2011)
3. Adachi, Nobuo: 5 articles (10/2022 - 12/2017)
4. Ishii, Yosuke: 5 articles (10/2022 - 12/2017)
5. Ishikawa, Masakazu: 5 articles (10/2022 - 12/2017)
6. Sunagawa, Toru: 5 articles (10/2022 - 12/2017)
7. Buckland, Aaron J: 5 articles (04/2022 - 01/2019)
8. Hamosh, Ada: 5 articles (01/2022 - 10/2015)
9. Rehm, Heidi L: 5 articles (01/2022 - 10/2015)
10. Calabresi, Peter A: 5 articles (10/2019 - 04/2013)

Related Diseases

1. Pain (Aches)
2. Neoplasms (Cancer)
3. Opioid-Related Disorders (Opiate Addiction)
01/01/2023 - "A logistic regression model was used to estimate the likelihood of opioid dependence/abuse after the first exposure based on their mental health conditions, prior substance abuse disorders, demographics, and the amount of MME per day patients received. "
01/01/2021 - "No significant differences were found based on incoming MME amounts, Current Opioid Misuse Measure (COMM) or Tampa Scale of Kinesiophobia (TSK) scores. "
01/01/2023 - "The authors' analysis illustrates that a postoperative opioid prescription of 225 MME or less is associated with improved patient satisfaction, greater improvement in physical function, and decreased opioid dependence compared with those who had > 225 MME prescribed."
01/01/2022 - "Multivariable regression was used to assess differential opioid misuse patterns by age group over time and in response to implementation of South Carolina's mandatory PDMP in 2017.Results: We found that between 2011 and 2018, older adults received 57% (p < .01) more in total MME and 25.4 days more (p < .01) in supply, but received prescriptions from fewer doctors (-0.063 doctors, p < 01) and pharmacies (-0.11 pharmacies, p < 01) per year versus younger adults. "
01/01/2022 - ": We used South Carolina's Reporting and Identification Prescription Tracking System from 2010 to 2018 to calculate an opioid misuse score for 193,073 patients (sex unknown) using days' supply, morphine milligram equivalents (MME), and the numbers of unique prescribers and dispensaries. "
4. Melanoma (Melanoma, Malignant)
5. Substance-Related Disorders (Drug Abuse)
01/01/2023 - "A logistic regression model was used to estimate the likelihood of opioid dependence/abuse after the first exposure based on their mental health conditions, prior substance abuse disorders, demographics, and the amount of MME per day patients received. "
11/01/2022 - "Overall, patients with a history of substance abuse were prescribed 31.2 MME more than those without (P < .0001), and patients with a history of chronic pain were prescribed 36.7 MME more than those without (P < .0001). "
10/01/2020 - "In the fully adjusted model, the following were associated with the highest adjusted odds ratios (aORs) for long-term use: older age (≥75 years, aOR 4.59, 95% CI 4.48-4.70, p < 0.001; 65-74 years, aOR 3.77, 95% CI 3.68-3.85, p < 0.001, compared to <35 years), social deprivation (Townsend score quintile 5/most deprived, aOR 1.56, 95% CI 1.52-1.59, p < 0.001, compared to quintile 1/least deprived), fibromyalgia (aOR 1.81, 95% CI 1.49-2.19, p < 0.001), substance abuse (aOR 1.72, 95% CI 1.65-1.79, p < 0.001), suicide/self-harm (aOR 1.56, 95% CI 1.52-1.61, p < 0.001), rheumatological conditions (aOR 1.53, 95% CI 1.48-1.58, p < 0.001), gabapentinoid use (aOR 2.52, 95% CI 2.43-2.61, p < 0.001), and MME/day at initiation (aOR 1.08, 95% CI 1.07-1.08, p < 0.001). "
07/19/2019 - "The authors derived a multivariate model based on the 5 most significant factors predictive of POI (number of surgical levels, intraoperative MME, liver disease, age, and history of substance abuse) and calculated relative POI risks using a derived 32-point system. "
01/01/2023 - "Patients who were depressed (OR = 2.09), previous non-opioid substance dependence or abuse (OR = 1.59) or received greater than 50 MME per day (OR = 1.03) showed statistically significant relationship with developing opioid dependence or abuse, while age (OR = -1.03) showed to be a protective factor. "

Related Drugs and Biologics

1. Opioid Analgesics (Opioids)
2. Morphine (MS Contin)
3. Buprenorphine (Subutex)
4. NF-kappa B (NF-kB)
5. Haloperidol (Haldol)
6. sodium phosphate (trisodium phosphate)
7. Proteins (Proteins, Gene)
8. Methadone (Dolophine)
9. Ketorolac
10. Metformin (Glucophage)

Related Therapies and Procedures

1. Length of Stay
2. Therapeutics
3. Enema (Enemas)
4. Pain Management
5. Perioperative Period